Personalized Treatment Plan If 5-Amino-1MQ is suitable, we design a dosing schedule, monitoring plan, and supportive protocols (nutrition, exercise)
Lilly announced meaningful price cuts to its tirzepatide-based obesity drug Zepbound, reducing out-of-pocket costs on its LillyDirect platform to as low as $299 for the starter dose and $449 for higher doses, just weeks after negotiating a separate price-cut agreement with the Trump Administration to secure Medicare access and tariff relief
Here we aim to utilize the functions in appetite inhibition and neuroprotection of GLP-1, in order to tailor our PEPDEX as a living machine that communicate with our central nervous systems and modulate our eating behavior, as well as improve our cognitive function to prevent neurodegenerative diseases
Wegovy (semaglutide) is a GLP-1 receptor agonist licensed in the UK for weight management in adults with obesity or overweight with weight-related comorbidities
Preclinical research has reported geroprotective, antioxidant, neuro-endocrine, and antimutagenic activities in multiple animal and cellular models, with proposed mechanisms including modulation of telomerase activity, preservation of telomere length, and possible epigenetic interactions with DNA and chromatin-associated proteins